ILMN:NASDAQ
Illumina Inc
$207.01
arrow_downward
-1.21%(-2.54) 1D
$205.00
arrow_downward
-0.97% (-2.01)bedtimeAfter hours
Closed: Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$209.08
High
$209.08
Low
$202.60
Mkt. cap
31.30B
Avg. vol.
2.46M
Volume
1.23M
P/E ratio
35.48
52-wk high
$309.34
52-wk low
$112.65
EPS
$5.83
Beta
1.46
Shares outstanding
151.20M
No. of employees
9K
Open
$209.08
High
$209.08
Low
$202.60
Mkt. cap
31.30B
Avg. vol.
2.46M
Volume
1.23M
P/E ratio
35.48
52-wk high
$309.34
52-wk low
$112.65
EPS
$5.83
Beta
1.46
Shares outstanding
151.20M
No. of employees
9K
News stories
From web sources and news partners
News Corp
·
10 hours ago
Illumina Inc. stock underperforms Friday when compared to competitors
MarketWatch
·
10 hours ago
Illumina Inc. stock underperforms Friday when compared to competitors
Benzinga
·
16 hours ago
Keith Meister Sells $61M Of Illumina Stock As Shares Slip Below Sale Price
Yahoo Finance
·
1 day ago
Illumina (ILMN) Stock Sees Modest Fair Value Lift As Analysts Debate Growth Outlook
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth Care
Industry-
Websiteillumina.com